| 1 |
34785775 | Inhibition of cathepsin K sensitizes oxaliplatin-induced apoptotic cell death by Bax upregulation through OTUB1-mediated p53 stabilization in vitro and in vivo. | 2022 Jan |
4 |
| 2 |
35235756 | Memantine ameliorates oxaliplatin-induced neurotoxicity via mitochondrial protection. | 2022 Mar |
1 |
| 3 |
35584569 | BAP1 phosphorylation-mediated Sp1 stabilization plays a critical role in cathepsin K inhibition-induced C-terminal p53-dependent Bax upregulation. | 2022 Jul |
1 |
| 4 |
34278473 | Oxaliplatin promotes siMAD2L2‑induced apoptosis in colon cancer cells. | 2021 Sep |
1 |
| 5 |
34862868 | Combined anti-cancer effects of curcumin and oxaliplatin on colon carcinoma colo205 cells using transplanted nude mice. | 2021 Sep |
4 |
| 6 |
32765688 | Inhibition of miR-96 enhances the sensitivity of colorectal cancer cells to oxaliplatin by targeting TPM1. | 2020 Sep |
1 |
| 7 |
31258699 | Reversal effect of ginsenoside Rh2 on oxaliplatin-resistant colon cancer cells and its mechanism. | 2019 Jul |
1 |
| 8 |
28463955 | Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway. | 2017 May 2 |
2 |
| 9 |
27565326 | Oxaliplatin-rapamycin combination was superior to mono-drug in treatment of hepatocellular carcinoma both in vitro and in vivo. | 2016 |
2 |
| 10 |
26547331 | [Effect of bafilomycin A1 on proliferation and oxaliplatin sensitivity in gastric cancer MGC-803 cells]. | 2015 Oct |
1 |
| 11 |
24486574 | Role of Bcl-xL/Beclin-1 in interplay between apoptosis and autophagy in oxaliplatin and bortezomib-induced cell death. | 2014 Mar 15 |
1 |
| 12 |
24515389 | Regulatory mechanism of ZNF139 in multi-drug resistance of gastric cancer cells. | 2014 Jun |
1 |
| 13 |
23180349 | Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients. | 2013 Jul |
2 |
| 14 |
23525071 | Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA. | 2013 Jul |
1 |
| 15 |
22741034 | Bax expression is predictive of favorable clinical outcome in chemonaive advanced gastric cancer patients treated with capecitabine, oxaliplatin, and irinotecan regimen. | 2012 Jun |
2 |
| 16 |
20503071 | Bax predicts outcome in gastric cancer patients treated with 5-fluorouracil, leucovorin, and oxaliplatin palliative chemotherapy. | 2011 Jan |
1 |
| 17 |
21683075 | Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL. | 2011 Aug |
3 |
| 18 |
21963225 | Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to α5β1 integrin and suppresses FAK/ERK/NF-κB signaling. | 2011 Dec 27 |
1 |
| 19 |
20128802 | Oxaliplatin responses in colorectal cancer cells are modulated by CHK2 kinase inhibitors. | 2010 Mar |
2 |
| 20 |
16804963 | Effects of recombinant human growth hormone on growth of human gastric carcinoma xenograft model in nude mice. | 2006 Jun 28 |
1 |
| 21 |
14985457 | Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect. | 2004 Feb |
3 |
| 22 |
15334062 | Oxaliplatin-induced mitochondrial apoptotic response of colon carcinoma cells does not require nuclear DNA. | 2004 Sep 30 |
2 |
| 23 |
15545975 | Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells. | 2004 Nov 29 |
2 |